NI
Nextech Invest Portfolio holdings
AUM
$528M
This Quarter Return
+40.57%
1 Year Return
-0.88%
3 Year Return
+164%
5 Year Return
–
10 Year Return
–
AUM
$330M
AUM Growth
+$330M
(+12%)
Cap. Flow
+$64.1M
Cap. Flow
% of AUM
19.42%
Top 10 Holdings %
Top 10 Hldgs %
97.93%
Holding
14
New
1
Increased
1
Reduced
1
Closed
–
Top Buys
| 1 |
Tango Therapeutics
TNGX
|
$62.3M |
| 2 |
Relay Therapeutics
RLAY
|
$2.08M |
Top Sells
| 1 |
PMV Pharmaceuticals
PMVP
|
$307K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Revolution Medicines
RVMD
$7.1B
| $134M | 40.59% | 4,839,529 | – | – |
|
|
2
Tango Therapeutics
TNGX
$747M
| $62.3M | 18.88% | +5,533,980 | New | +$62.3M |
|
3
Tyra Biosciences
TYRA
$675M
| $34.7M | 10.51% | 2,518,582 | – | – |
|
|
EQRX
4
DELISTED
EQRx, Inc. Common Stock
EQRX
| $29.1M | 8.82% | 13,104,424 | – | – |
|
5
Oric Pharmaceuticals
ORIC
$994M
| $25.9M | 7.86% | 4,285,714 | – | – |
|
6
Cullinan Oncology
CGEM
$445M
| $11.1M | 3.35% | 1,221,145 | – | – |
|
|
7
Relay Therapeutics
RLAY
$619M
| $10.1M | 3.05% | 1,196,409 +247,750 | +26% | +$2.08M |
|
8
ARS Pharmaceuticals
SPRY
$1.15B
| $7.22M | 2.19% | 1,910,029 | – | – |
|
9
Arvinas
ARVN
$568M
| $5.64M | 1.71% | 287,251 | – | – |
|
|
KNTE
10
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $3.26M | 0.99% | 2,329,480 | – | – |
|
|
11
PMV Pharmaceuticals
PMVP
$74.2M
| $2.59M | 0.78% | 421,284 -50,000 | -11% | -$307K |
|
|
KRON
12
DELISTED
Kronos Bio
KRON
| $1.89M | 0.57% | 1,451,537 | – | – |
|
|
THRX
13
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
| $1.64M | 0.5% | 611,310 | – | – |
|
14
C4 Therapeutics
CCCC
$185M
| $699K | 0.21% | 375,857 | – | – |
|